Eli Lilly (LLY) CEO Dave Ricks said Britain was likely the “worst country in Europe” for drug prices, adding the country may miss out on new drugs if it did not raise its prices and scrap a rebate scheme that requires companies to contribute part of their U.K. drug revenue to the NHS, Muvija M of Reuters reports, citing an interview.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- Eli Lilly (LLY) to Build $6.5 Billion Manufacturing Plant in Texas
- Eli Lilly to build new $6.5B facility in Houston, Texas
- Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
- Jim Cramer Rethinks His Bullish Stance on Eli Lilly Stock (LLY)
- Eli Lilly & Co’s Promising Growth Prospects Reinforced by Orfo Study Success and Strategic Patient-Centric Approach